Skip to main content Help with accessibility Skip to main navigation

DEXAMETHASONE INTRAVITREAL IMPLANT (Ozurdex®) for treating visual impairment caused by diabetic macular oedema

CCG Approval Status:

Ha
Kn
Li
SF
SS
SH
Wa
WL
Wi
Date Added: 26 - Oct - 2022
Body System:
Red
DEXAMETHASONE INTRAVITREAL IMPLANT (Ozurdex®) for treating visual impairment caused by diabetic macular oedema

The Pan Mersey Area Prescribing Committee recommends the prescribing of DEXAMETHASONE INTRAVITREAL IMPLANT (Ozurdex®), by specialists only, for treating visual impairment caused by diabetic macular oedema, in accordance with NICE TA824.

NHS Cheshire and Merseyside APPROVED